维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Sahz LB"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer 显示文摘	Sahz LB Cox JV Blanke C	2000	N Engl J Med2000，343，13：	1
2	Irinotecan( CPT-11 ) is an active agent in untreated patients with metastatic colorectal cancer显示文摘	Conti JA Kemeny NE Sahz LB	1996	J Clin Onco11996，14，3：	1
3	D i az-Rubio E Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer, a randomized phase Ⅲ study 显示文摘	Sahz LB Clarke S	2008	J Clin Oncol2008，26，10：	1
4	Bevacizumab (Bev) in combination with XELOX or FOLFOX4 : efficacy results from XELOX-1/ NO16966,a randomized phase Ⅲ trial in the first-line treatment of metastatic colorectal cancer (MCRC) 显示文摘	Sahz LB Clarke S Diaz-Rubio E	2007	Proc Am Soc Clin Oncol2007，，18：	1
5	Managing chemotherapy - induced diarrhea显示文摘	Sahz LB	2006	Clin Adv Hematol Oncol2006，4，3：	1
6	Bevacizumab in combination with oxaliplatin-based chemotherapy as firstline therapy in metastatic colorectal cancer: a randomized phase Ⅲ study 显示文摘	Sahz LB Clarke S Diaz-Rubio E	2008	J Clin Oncol2008，26，：	1
7	Bevacizumab in combination with oxaliplatin-based chemotherapy as first- line therapy in metastatic colorectal cancer: a random- ized phase II显示文摘	Sahz LB Clarke S Diaz-Rubio E	2008	J Clin Oncol2008，26，12：	1
8	Phase Ⅱ trial of cetuximab in patients with refractory coloreetal cancer that expresses the epidermal growth factor receptor 显示文摘	Sahz LB Meropol N J Loehrer PJ Sr	2004	J Clin Oncol2004，22，7：	1
9	Irinotecan is an active agent in untreated patients with metastatic colorectal cancer 显示文摘	Conti JA Kemeny NE Sahz LB	1996	J Clin Oncol1996，14，3：	1
10	BevacizLLmab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer : A randomized phase III study 显示文摘	Sahz LB Clarke S Diaz-Rubio E	2008	J Clin Oncol2008，26，12：	1
11	Venous thromboem- bolic events with chemotherapy plus bevacizumab: a pooled anal- ysis of patients in randomized phase II and III studies显示文摘	Hurwitz HI Sahz LB Van Cutsem E	2011	J Clin Oncol2011，29，13：	1
12	Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor显示文摘	Sahz LB Meropol N J Loehrer PJ Sr	2004	J Clin Oncol2004，22，7：	1
13	Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer 显示文摘	Sahz LB Cox JV Blank C	2000	N Engl J Med2000，34，3：	1
14	Irinotecan plus fluorouracil/leucovoria for metastatic colorectal cancer a new surviral standard 显示文摘	Sahz LB Douillard JY Pirotta N	2001	Oncologist2001，6，：	1
15	Bevacizumab in combination with oxaliplatin based chemotherapy as first line therapy in metastatic colorectal cancer: a randomized phase Ⅲ study显示文摘	Sahz LB Clarke S Diaz Rubio E	2008	J Clin Oncol2008，26，12：	1
16	Phase Ⅱ trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor显示文摘	Sahz LB Meropol NJ Loehrer PJ Sr	2004	J Clin Oncol2004，22，：	1
17	Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy 显示文摘	Sahz LB Rosen LS Marshall JL et M	2007	J Clin Oncol2007，25，30：	1
18	Irinotecan plus fluorouracil and leucovorin for metastatic colorecatal cancer 显示文摘	Sahz LB Cox JV Blanke C	2000	N Engl J Med2000，343，：	1
19	Bevacizumab in combi- nation with oxaliplatin-based chemotherapy as first-line therapy in metastatic eoloreetal cancer: a randomized phase 1 study 显示文摘	Sahz LB Clarke S Dlaz-Rubio E	2008	J ClinOncol2008，26，12：	1
20	Managing chemotherapy-induced diarrheal 显示文摘	Sahz LB	2006	Clin Adv Hematol Oncol2006，4，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示